Online Exclusives

Contract Pharma’s Top Breaking News Stories of 2025

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights.

Here’s your yearly recap—the most viewed breaking news stories on our site for 2025.

This year, Contract Pharma readers gravitated toward stories that reflected a year defined by rapid technological advancement, strategic consolidation, and shifting priorities across the pharmaceutical and bioprocessing landscape. The most‑viewed breaking news headlines reveal an industry simultaneously innovating at high speed and recalibrating in response to economic, workforce, and scientific pressures.

From Thermo Fisher’s continued push into automation and single‑use bioprocessing, to high‑profile restructurings and acquisitions, to fresh investment in cutting‑edge therapies and sustainable manufacturing, the topics that drew the most attention chart a clear map of where the sector is heading. These top stories not only captured reader interest—they captured the defining movements shaping pharma and biotech in 2025.

Contract Pharma’s Top Breaking News Stories of 2025

1. Thermo Fisher Scientific Introduces Automated Plasmid DNA Purification Kit

2. Thermo Fisher Scientific, Sanofi Expand Strategic Partnership

3. Novo Nordisk Restructures, Reduces Workforce by 11%

4. Upperton Pharma Solutions Awarded VaxHub Sustainable Grant

5. QIAGEN Expands Its Digital PCR Portfolio with Lentivirus Solutions

6. Thermo Fisher Scientific Introduces 5L DynaDrive Single-Use Bioreactor

7. KBI Biopharma, Infinimmune Partner to Support Antibody Manufacturing

8. Anocca Raises $46M to Advance Clinical Trial Targeting Pancreatic Cancer

9. GSK Acquires IDRx

10. Ardena Acquires Catalent’s Drug Product Manufacturing Facility in Somerset, NJ

11. Thermo Fisher Scientific Acquires NJ Site from Sanofi

Contract Pharma thanks its loyal readers for another great year and wishes everyone a wonderful 2026!

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters